68Ga-FAPI-PET/CT在颈外原发灶不明肿瘤中的头对头比较
本研究回顾性纳入13例颈外原发灶不明肿瘤(CUP)患者,均行68Ga-FAPI-46与18F-FDG PET/CT头对头比较。结果显示68Ga-FAPI-PET/CT在器官转移灶的组织对比度更高,并额外检出5/21处18F-FDG不清晰的转移灶,但两种示踪剂均未提高原发灶检出率。
要点
- 68Ga-FAPI-PET/CT在器官转移灶的组织对比度优于18F-FDG。
- 68Ga-FAPI-PET/CT额外检出5/21处18F-FDG不清晰的转移灶。
- 两种示踪剂均未提高颈外CUP的原发灶检出率。
核心结论
- 由于器官内组织对比度更高,68Ga-FAPI-PET/CT在疑似非淋巴结远处转移的颈外CUP患者中可能优于18F-FDG-PET/CT。
研究设计与样本
- 回顾性研究,纳入13例颈外CUP患者,均行18F-FDG和68Ga-FAPI-PET/CT,分析21处转移灶的SUVmax/mean、TBRmax/mean和TTRmax/mean。
主要发现
- 共分析3例单发和6例寡转移CUP患者的21处转移灶,4例既往切除转移灶者无摄取。
- 所有转移灶的TBRmax差异显著,器官转移灶的TTRmax差异显著。
- 68Ga-FAPI-PET/CT检出5/21处18F-FDG-PET/CT无法清晰分辨的额外转移灶。
- 两种示踪剂均未观察到原发灶检出率提高。
关键数值与推荐
- 感兴趣区技术采用50%等轮廓 delineation,分析SUVmax/mean、TBRmax/mean和TTRmax/mean。
- 对数据进行对数转换以满足模型假设并稳定方差,以对数转换后的示踪剂摄取差值作为结局变量。
临床怎么用
- 对于疑似非淋巴结远处转移的颈外CUP患者,可考虑使用68Ga-FAPI-PET/CT以改善器官转移灶的检出。
- 不应期望68Ga-FAPI-PET/CT提高颈外CUP的原发灶检出率。
局限性
- 回顾性设计且样本量小(13例患者,21处转移灶)。
- 4例既往切除转移灶者无摄取,可能影响分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Oncological treatment in a substantial portion of patients with cancer of unknown primary (CUP) remains challenging due to limitations of conventional imaging and positron emission tomography/computed tomography with 18Fluor-fluorodeoxyglucose (18F-FDG-PET/CT). In head and neck-like CUP (HNCUP), several studies found significantly higher tracer-uptake and detection rates of primary tumors in 68Gallium-labeled fibroblast activation protein inhibitor-PET/CT (68Ga-FAPI-PET/CT). Here, we address a gap in CUP literature by retrospectively evaluating the diagnostic accuracy of both tracer in a head-to-head comparison of patients with single-site and oligometastatic extra-cervical CUP. METHODS: 13 patients with extra-cervical CUP underwent both 18F-FDG- and 68Ga-FAPI-PET/CT. Suspicious PET-positive lesions were delineated using the volume of interest-technique (50%-isocontour) followed by analysis of maximum and mean standardized uptake values (SUVmax/mean), target-to-background ratios (TBRmax/mean) and tumor-to-tissue ratios (TTRmax/mean). Descriptive analysis was performed and log-transformation was applied to meet model assumptions and stabilize variance. The difference between log-transformed 68Ga-FAPI- and 18F-FDG-uptake values was used as outcome variables. RESULTS: 21 metastases of 3 patients with single-site and 6 patients with oligometastasized CUP were analyzed. 4 patients with previously extirpated metastases showed no uptake. No increased detection rate of primary tumors could be observed by either tracer. Differences of TBRmax in all metastatic sites and of TTRmax in organ metastases were significant. 68Ga-FAPI-PET/CT lead to detection of 5/21 additional metastases which were not clearly distinguishable in 18F-FDG-PET/CT. CONCLUSION: Due to higher tissue contrast in organs, our findings suggest that 68Ga-FAPI-PET/CT appears favourable compared to 18F-FDG-PET/CT particularly in patients with suspected distant metastases other than lymph nodes.
引用
- Spektor AM, Zapata Bonilla SA, Mildenberger P, et al. 68Ga-FAPI-PET/CT in extra-cervical CUP: Head-to-Head Comparison of 68Ga-FAPI-46 with 18F-FDG in 13 patients. Eur J Nucl Med Mol Imaging. 2026. PMID: 42171731. doi:10.1007/s00259-026-07916-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。